Aperio Group’s MEDIVATION, INC. MDVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-47,440
Closed -$2.86M 2117
2016
Q2
$2.86M Buy
47,440
+8,005
+20% +$454K 0.02% 686
2016
Q1
$1.81M Buy
39,435
+14,855
+60% +$539K 0.02% 815
2015
Q4
$1.19M Buy
24,580
+9,369
+62% +$404K 0.01% 944
2015
Q3
$646K Sell
15,211
-1,989
-12% -$98.5K 0.01% 1169
2015
Q2
$982K Buy
17,200
+3,440
+25% +$212K 0.01% 978
2015
Q1
$888K Buy
13,760
+1,620
+13% +$92.8K 0.01% 978
2014
Q4
$605K Buy
12,140
+2,160
+22% +$112K 0.01% 1132
2014
Q3
$493K Buy
9,980
+1,430
+17% +$60.8K 0.01% 1141
2014
Q2
$330K Buy
8,550
+1,034
+14% +$34.9K ﹤0.01% 1342
2014
Q1
$242K Buy
+7,516
New +$277K ﹤0.01% 1757
2013
Q4
Sell
-6,812
Closed -$206K 1631
2013
Q3
$204K Buy
+6,812
New +$194K ﹤0.01% 1640

Other funds holding MDVN

Aperio Group's MDVN Position: Q3 2016 in Review

Aperio Group sold out of MEDIVATION, INC. (MDVN) in Q3 2016, closing a stake of 47,440 shares — an estimated $2.86M sold.

Aperio Group first reported a position in MDVN in Q3 2013 and held it in 11 quarters. The position peaked at $2.86M in Q2 2016. 53 funds tracked by Wall St. Rank hold MDVN as of Q3 2016.

  • Aperio Group reported no remaining MEDIVATION, INC. position as of Q3 2016 after selling out during the quarter.
  • Aperio Group sold 47,440 MEDIVATION, INC. shares in Q3 2016, an estimated $2.86M.
  • Aperio Group first reported a position in MEDIVATION, INC. in Q3 2013 and held it in 11 quarters.
  • Aperio Group's MEDIVATION, INC. position peaked at $2.86M in Q2 2016.
  • 53 funds tracked by Wall St. Rank held MEDIVATION, INC. as of Q3 2016.

Based on Aperio Group's 13F filing for Q3 2016, filed 2 Nov 2016.